Morepen Laboratories Limited (NSE:MOREPENLAB)
India · Delayed Price · Currency is INR 119.19
-3.16 (-2.58%)
Sep 24, 2026, 11:55 AM IST
Morepen Laboratories Market Cap
Morepen Laboratories has a market cap or net worth of 67.04 billion as of September 23, 2026. Its market cap has increased by 129.85% in one year.
Market Cap
67.04B
Enterprise Value
68.21B
Revenue
19.51B
Ranking
n/a
PE Ratio
47.71
Stock Price
119.19
ChartMarket Cap Chart
Since October 8, 1999, Morepen Laboratories's market cap has increased from 8.66B to 67.04B, an increase of 674.34%. That is a compound annual growth rate of 7.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 67.04B | 197.91% |
| Dec 31, 2025 | 22.50B | -47.55% |
| Dec 31, 2024 | 42.90B | 72.95% |
| Dec 29, 2023 | 24.81B | 28.39% |
| Dec 30, 2022 | 19.32B | -23.70% |
| Dec 31, 2021 | 25.33B | 83.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NATCO Pharma | 146.21B |
| Sudeep Pharma | 130.46B |
| Akums Drugs and Pharmaceuticals | 125.77B |
| Strides Pharma Science | 112.43B |
| Aarti Pharmalabs | 76.74B |
| Innova Captab | 68.57B |
| Sun Pharma Advanced Research Company | 62.93B |
| Orchid Pharma | 50.20B |